NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128472&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=128471&wire=1 or contact Joseph E. Levi, Esq.

image for news Class Action Filed Against TELUS International (Cda) Inc. (TIXT) Seeking Recovery for Investors - Contact Levi & Korsinsky

D&H Canada expands its relationship with HP Canada, extending its value proposition to partners through retail, industry, and commercial print solutions.

image for news D&H Canada Strengthens Portfolio With Addition of HP Commercial Printers and Retail Industry Solutions

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.

image for news Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT

AMD: Don't Be Fooled By The Hype (Rating Downgrade) — Negative

AMD   Seeking Alpha — February 10, 2025

Advanced Micro Devices, Inc.'s Q4 earnings report revealed strong revenue growth but highlighted concerns about stagnant data center operating margins and limited future growth prospects. Despite significant hype and innovation, AMD's forward P/E ratio requires cautious analysis due to potential risks and compressed margins. AMD's guidance for Q1 2025 indicates limited growth, raising concerns about capitalizing on the current AI and cloud infrastructure investment wave.

image for news AMD: Don't Be Fooled By The Hype (Rating Downgrade)

Should Cisco Systems Stock be in Your Portfolio Pre-Q2 Earnings? — Positive

CSCO   Zacks Investment Research — February 10, 2025

CSCO's second-quarter fiscal 2025 performance is likely to reflect improving demand in the networking domain and strong growth in the Security business.

image for news Should Cisco Systems Stock be in Your Portfolio Pre-Q2 Earnings?

Strength Seen in SolarWinds (SWI): Can Its 21.8% Jump Turn into More Strength? — Positive

SWI   Zacks Investment Research — February 10, 2025

SolarWinds (SWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

image for news Strength Seen in SolarWinds (SWI): Can Its 21.8% Jump Turn into More Strength?

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025.

image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities lawsuit.

image for news Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT) of a class action securities lawsuit.

image for news Shareholders that lost money on Nextracker Inc.(NXT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Lyft Reportedly Plans Robotaxi Launch As Soon As 2026 — Positive

LYFT   PYMNTS — February 10, 2025

Lyft is reportedly aiming to bring autonomous robotaxis to its app as soon as next year. The service would launch first in Dallas with additional markets to follow, TechCrunch reported Monday (Feb. 10), citing comments from a company executive.

image for news Lyft Reportedly Plans Robotaxi Launch As Soon As 2026

Ensign Group Shares Plunge 12% Despite Q4 Earnings Beat — Neutral

ENSG   Zacks Investment Research — February 10, 2025

ENSG's fourth-quarter results gain on strong contribution from the Skilled Services unit, partly offset by the escalating cost of services. It estimates 2025 adjusted EPS to be within $6.16-$6.34.

image for news Ensign Group Shares Plunge 12% Despite Q4 Earnings Beat

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit.

image for news Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Work Completed to Meet Future Energy Demands in Western Pennsylvania — Neutral

FE   PRNewsWire — February 10, 2025

FirstEnergy line rebuild to benefit 500 West Penn Power customers GREENSBURG, Pa. , Feb. 10, 2025 /PRNewswire/ -- FirstEnergy Pennsylvania Electric Company (FE PA), a subsidiary of FirstEnergy Corp. (NYSE: FE) doing business as West Penn Power in western Pennsylvania, has upgraded its electric system in eastern Westmoreland County to help prevent service disruptions, support voltage and accommodate growth.

image for news Work Completed to Meet Future Energy Demands in Western Pennsylvania

Stock Of The Day: Axon Near Buy Point As Cup (Almost) Runneth Over With AI, Drone Success — Positive

AXON   Investors Business Daily — February 10, 2025

Stock Of The Day: Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.

image for news Stock Of The Day: Axon Near Buy Point As Cup (Almost) Runneth Over With AI, Drone Success

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innovative Industrial Properties, Inc. ("Innovative Industrial Properties" or the "Company") (NYSE: IIPR) of a class action securities lawsuit.

image for news Innovative Industrial Properties, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 18, 2025 to Discuss Your Rights – IIPR

Hims & Hers Super Bowl ad draws scrutiny from lawmakers — Neutral

HIMS   Yahoo Finance — February 10, 2025

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health experts and US lawmakers over the exclusion of potential side effects tied to GLP-1 weight-loss treatments in the advertisement.

image for news Hims & Hers Super Bowl ad draws scrutiny from lawmakers

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128468&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Nextracker Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 25, 2025 - NXT

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=128470&wire=1 or contact Joseph E. Levi, Esq.

image for news Micron Technology, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - MU

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of two new patent applications, covering groundbreaking developments in the treatment of glioma, an aggressive brain cancer, and hematologic malignancies, a complex group of blood cancers. The patent application for glioma has been filed under number N2039647, while the second application, numbered N2039645, focuses on hematologic …

image for news Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market